Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

Published Date: 04 Jun 2024

Forty percent of patients responded to frontline treatment with mitazalimab plus mFOLFIRINOX.

Read Full News

Latest News

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Terminology also makes a difference

Liver Failure or Liver Mets?

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Latest News

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Terminology also makes a difference

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Ureteroscopy and histopathology should be considered as routine preoperative assessments

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

News All Time

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer

Death risk cut by 54% with B7-H3-targeting tambotatug pelitecan and risvutatug rezetecan

Nurse Accused of Exorcism; Death After 8 Hours of Plastic Surgery; Top Cancer Months

Health news and commentary gathered by MedPage Today staff

Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer

Omitting prophylactic cranial irradiation led to improved cognitive failure-free survival

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

All responding NCCN members reported shortages, priorities identified but solutions still needed

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Practice-changing median of 14.3 months with T-DXd, but caution over early unfavorable OS trend

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

News, features, and commentary about cancer-related issues

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

— Comments were noncommittal in agency document released ahead of advisors' meeting

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Recommended News For You

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.

Early PET May Help Tailor Therapy in Hodgkin Lymphoma

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

Medical debt in collections persists after cancer diagnosis

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

Independent Risk Factors for "Deaths of Despair" Found.

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

Recommended Articles For You

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care 

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition 

Drug Safety Through Oncology Survivorship Medication Monitoring Frameworks 

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It Is Not Just the Royals Who Go Through Cancer.

2.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

3.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

4.

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

5.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

1.

Tumor Microenvironment Reprogramming for Regenerative Cancer Recovery

2.

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer

3.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

4.

Exercise Rehabilitation in Hematologic Disease Survivorship

5.

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

3.

Navigating the Complexities of Ph Negative ALL - Part VIII

4.

Current Scenario of Cancer- Q&A Session to Close the Gap

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot